28 filings · most recent first
CRL 8-K Filings
Charles River Laboratories Announces Divestitures And Updates 2026 Guidance
Charles River Labs To Present At Jp Morgan Conference And Announce Acquisitions
Charles River Laboratories Announces Leadership Transition
Charles River Labs To Discuss Fourthquarter Demand Trends At Evercore Conference
Sec Investigation Concludes With No Enforcement Action For Charles River Labs
Charles River Labs Q4 2023 Results Revenue Decline And Earnings Miss
Charles River Labs Reports Q2 2026 Results And Raises Guidance
Charles River Labs Reports Q1 2026 Results Gaap Loss Nongaap Eps 206
Charles River Laboratories Reports 2025 Results And Provides 2026 Guidance
Charles River Labs Q3 2025 Financial Results And Updated Guidance
Charles River Laboratories Reports Strong Q2 2025 Results And Updates Guidance
Charles River Labs Extends Ceos Employment And Elects New Board Members
Charles River Labs Announces Firstquarter 2025 Results And Raises Guidance
Charles River Laboratories Execs Purchase Shares In Confidence Of Companys
Charles River Laboratories Announces Fourthquarter And Fullyear 2024 Results
Charles River Labs Presents Preliminary 2025 Financial Outlook At Jp Morgan
Charles River Labs Reports Thirdquarter 2024 Financial Results
Charles River Labs Q2 2024 Earnings And New Stock Repurchase
Charles River Labs Shareholders Elect New Board Members And Approve Key
Charles River Labs Reports Q1 2024 Financial Results
Charles River Labs Appoints New Director
Charles River Labs Announces Retirement Of Chief Commercial Officer And
Charles River Labs Approves 2026 Longterm Incentive Plan
Charles River Labs Appoints Glenn Coleman As New Cfo
Charles River Labs Announces Cfo Resignation And Interim Cfo Appointment With
Charles River Labs Announces Interim Cfo Appointment Following Cfo Resignation
Charles River Laboratories Announces Governance Updates And Strategic Review
Charles River Labs Amends Credit Agreement